(Q39385067)

11 September 2017

Efficacy and side effects of praziquantel against Schistosoma mansoni in a community of western Côte d'Ivoire (English)

1 reference

11 September 2017

1 reference

1 reference

inferred from abstract

1 reference

1 reference

10

Jürg Utzinger

0 references

Penelope Vounatsou

series ordinal

8

object named as

Penelope Vounatsou

0 references

Marcel Tanner

series ordinal

9

object named as

Marcel Tanner

1 reference

11 September 2017

1

Giovanna Raso

1 reference

11 September 2017

7

Isaac I Bogoch

1 reference

11 September 2017

2

Eliézer K N'Goran

1 reference

11 September 2017

3

Abale Toty

1 reference

11 September 2017

4

Anne Luginbühl

1 reference

11 September 2017

6

Norbert T Tian-Bi

1 reference

11 September 2017

Cynthia A Adjoua

5

1 reference

PubMed ID

14702835

11 September 2017

language of work or name

1 reference

1 January 2004

1 reference

Transactions of the Royal Society of Tropical Medicine and Hygiene

11 September 2017

1 reference

11 September 2017

98

1 reference

11 September 2017

1

1 reference

11 September 2017

18-27

1 reference

Herd immunity to helminth infection and implications for parasite control.

11 September 2017

0 references

1 reference

https://api.crossref.org/works/10.1016%2FS0035-9203%2803%2900003-8

7 January 2021

Implications of faecal egg count variation when using the Kato-Katz method to assess Schistosoma mansoni infections

1 reference

https://api.crossref.org/works/10.1016%2FS0035-9203%2803%2900003-8

7 January 2021

Schistosomiasis: from risk assessment to control

1 reference

https://api.crossref.org/works/10.1016%2FS0035-9203%2803%2900003-8

7 January 2021

Praziquantel side effects and efficacy related to Schistosoma mansoni egg loads and morbidity in primary school children in north-east Ethiopia

1 reference

https://api.crossref.org/works/10.1016%2FS0035-9203%2803%2900003-8

7 January 2021

Praziquantel: is there real resistance and are there alternatives?

1 reference

https://api.crossref.org/works/10.1016%2FS0035-9203%2803%2900003-8

7 January 2021

https://api.crossref.org/works/10.1016%2FS0035-9203%2803%2900003-8

1 reference

7 January 2021

Interpreting low praziquantel cure rates of Schistosoma mansoni infections in Senegal

1 reference

https://api.crossref.org/works/10.1016%2FS0035-9203%2803%2900003-8

7 January 2021

Underestimation of Schistosoma mansoni prevalences.

1 reference

https://api.crossref.org/works/10.1016%2FS0035-9203%2803%2900003-8

7 January 2021

Validation of a model for variations in Schistosoma mansoni egg counts

1 reference

https://api.crossref.org/works/10.1016%2FS0035-9203%2803%2900003-8

7 January 2021

Is Schistosomicidal Chemotherapy Sub-curative? Implications for Drug Resistance

1 reference

https://api.crossref.org/works/10.1016%2FS0035-9203%2803%2900003-8

7 January 2021

Resistance of Schistosoma mansoni to praziquantel: is there a problem?

1 reference

https://api.crossref.org/works/10.1016%2FS0035-9203%2803%2900003-8

7 January 2021

Comparison of the direct faecal smear and two thick smear techniques for the diagnosis of intestinal parasitic infections

1 reference

https://api.crossref.org/works/10.1016%2FS0035-9203%2803%2900003-8

7 January 2021

Drugs for the control of parasitic diseases: current status and development in schistosomiasis

1 reference

https://api.crossref.org/works/10.1016%2FS0035-9203%2803%2900003-8

7 January 2021

On the use of age-intensity data to detect immunity to parasitic infections, with special reference to Schistosoma mansoni in Kenya

1 reference

https://api.crossref.org/works/10.1016%2FS0035-9203%2803%2900003-8

7 January 2021

Drug resistance in human helminths: current situation and lessons from livestock

1 reference

https://api.crossref.org/works/10.1016%2FS0035-9203%2803%2900003-8

7 January 2021

Field trials of praziquantel and oxamniquine for the treatment of schistosomiasis mansoni in Burundi.

1 reference

https://api.crossref.org/works/10.1016%2FS0035-9203%2803%2900003-8

7 January 2021

Are poor responses to praziquantel for the treatment of Schistosoma mansoni infections in Senegal due to resistance? An overview of the evidence.

1 reference

https://api.crossref.org/works/10.1016%2FS0035-9203%2803%2900003-8

7 January 2021

Methods for estimation of associations between multiple species parasite infections.

1 reference

https://api.crossref.org/works/10.1016%2FS0035-9203%2803%2900003-8

7 January 2021

Use of praziquantel against schistosomiasis: a review of current status.

1 reference

https://api.crossref.org/works/10.1016%2FS0035-9203%2803%2900003-8

7 January 2021

Praziquantel--its use, cost and possible development of resistance.

1 reference

https://api.crossref.org/works/10.1016%2FS0035-9203%2803%2900003-8

7 January 2021

Efficacy and side-effects of two praziquantel treatments against Schistosoma haematobium infection, among schoolchildren from Côte d'Ivoire

1 reference

https://api.crossref.org/works/10.1016%2FS0035-9203%2803%2900003-8

7 January 2021

Efficacy of praziquantel against Schistosoma mansoni in northern Senegal

1 reference

https://api.crossref.org/works/10.1016%2FS0035-9203%2803%2900003-8

7 January 2021

Side effects of praziquantel in the treatment of Schistosoma mansoni in Maniema, Zaire

1 reference

https://api.crossref.org/works/10.1016%2FS0035-9203%2803%2900003-8

7 January 2021

An international initiative on praziquantel use.

1 reference

https://api.crossref.org/works/10.1016%2FS0035-9203%2803%2900003-8

7 January 2021

Schistosoma mansoni: chemotherapy of infections of different ages

1 reference

https://api.crossref.org/works/10.1016%2FS0035-9203%2803%2900003-8

7 January 2021

Schistosomiasis and soil-transmitted helminth infections: forging control efforts

1 reference

https://api.crossref.org/works/10.1016%2FS0035-9203%2803%2900003-8

7 January 2021

Efficacy and side effects of praziquantel in an epidemic focus of Schistosoma mansoni.

1 reference

https://api.crossref.org/works/10.1016%2FS0035-9203%2803%2900003-8

7 January 2021

Schistosoma mansoni, intestinal parasites and perceived morbidity indicators in schoolchildren in a rural endemic area of western Côte d'Ivoire

1 reference

https://api.crossref.org/works/10.1016%2FS0035-9203%2803%2900003-8

7 January 2021

Efficacy of praziquantel against Schistosoma mansoni with particular consideration for intensity of infection

1 reference

https://api.crossref.org/works/10.1016%2FS0035-9203%2803%2900003-8

7 January 2021

Relative contribution of day-to-day and intra-specimen variation in faecal egg counts of Schistosoma mansoni before and after treatment with praziquantel

1 reference

https://api.crossref.org/works/10.1016%2FS0035-9203%2803%2900003-8

7 January 2021

Combination chemotherapy of schistosomiasis in laboratory studies and clinical trials

1 reference

https://api.crossref.org/works/10.1016%2FS0035-9203%2803%2900003-8

7 January 2021

Patterns in parasite epidemiology: the peak shift

1 reference

https://api.crossref.org/works/10.1016%2FS0035-9203%2803%2900003-8

7 January 2021

Effects of praziquantel on different developmental stages of Schistosoma mansoni in vitro and in vivo.

1 reference

https://api.crossref.org/works/10.1016%2FS0035-9203%2803%2900003-8

7 January 2021

10.1016/S0035-9203(03)00003-8

Identifiers

DOI

1 reference

11 September 2017

1 reference

PubMed ID

14702835